StockTipsArenaBeta

BUY Aurobindo Pharma — Manas Jaiswal

BUYAurobindo Pharma
Aurobindo Pharma share price target & all analyst calls

byManas JaiswalHorizon: NA (inferred Swing (≤2wk))17 Sept 2026via CNBC Awaaz.

Entry₹1,683.2Inferred
Target₹1,730
Total upside +2.78% (call closed)
Stop loss₹1,669-0.84% risk
Exit₹1,73018 Sept 2026, 3:30 pm
Target hit+2.78%0.00%upside left
Follow Manas Jaiswal for new calls(32% target hit, 411 closed calls)Get alertsWatch AUROPHARMA for new buy/sell callsGet alertsSee 204 active Swing picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

Frozen at close · 18 Sept 2026
8 supporting1 opposing
Supports the BUY call (8)

JM Financial sees up to 28% upside in Dr Reddy’s and Aurobindo Pharma. Should you buy?

NewsEt-Markets·16 Sept · 2d ago

(opens in new tab)

Aurobindo Pharma Gets First USFDA Nod For First Metered-Dose Inhaler

NewsNdtv-Profit·15 Sept · 2d ago

(opens in new tab)

Aurobindo Pharma gets US FDA nod to sell first metered-dose asthma inhaler in US

NewsCnbc-Tv18·15 Sept · 3d ago

(opens in new tab)

Aurobindo Pharma received final US FDA approval for its Beclomethasone Dipropionate HFA Inhalation Aerosol in 40 mcg and 80 mcg strengths.

BSE · Company Update·15 Sept · 3d ago

(opens in new tab)

Aurobindo Pharma has received final approval from the USFDA for its Beclomethasone Dipropionate HFA Inhalation Aerosol in 40 mcg and 80 mcg strengths.

NSE · Press Release·15 Sept · 3d ago

(opens in new tab)
Neutral / worth noting (0)

Nothing found in this tip’s window yet.

Weighs against the BUY call (1)

1 advisor has an active short-term SELL call on this stock

Advisor consensus · adjacent horizon·6 Aug · 1mo ago

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Aurobindo Pharma

All analyst calls on Aurobindo Pharma

More from Manas Jaiswal

Every call and its outcome